NCT02226276 2026-02-13Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast CancerCity of Hope Medical CenterPhase NA Active not recruiting10 enrolled 8 charts